XETRA - Delayed Quote EUR

Biotest Aktiengesellschaft (BIO.DE)

41.20 -0.40 (-0.96%)
As of 3:52 PM GMT+2. Market Open.
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
684,600.00
684,600.00
516,100.00
515,600.00
484,200.00
Cost of Revenue
404,300.00
404,300.00
391,200.00
434,900.00
354,100.00
Gross Profit
280,300.00
280,300.00
124,900.00
80,700.00
130,100.00
Operating Expense
160,200.00
160,200.00
133,400.00
132,800.00
132,600.00
Operating Income
120,100.00
120,100.00
-8,500.00
-52,100.00
-2,500.00
Net Non Operating Interest Income Expense
-38,200.00
-38,200.00
-22,800.00
-15,700.00
-15,800.00
Pretax Income
106,300.00
106,300.00
-30,800.00
-62,600.00
-30,000.00
Tax Provision
-20,700.00
-20,700.00
800.00
700.00
1,400.00
Net Income Common Stockholders
127,000.00
127,000.00
-32,100.00
-63,800.00
-31,800.00
Diluted NI Available to Com Stockholders
127,000.00
127,000.00
-32,100.00
-63,800.00
-31,800.00
Basic EPS
2.29
3.20
-0.81
-1.61
-0.80
Diluted EPS
2.29
3.20
-0.81
-1.61
-0.80
Basic Average Shares
39,571.45
39,571.45
39,571.45
39,571.45
39,571.45
Diluted Average Shares
39,571.45
39,571.45
39,571.45
39,571.45
39,571.45
Total Operating Income as Reported
143,500.00
143,500.00
-16,600.00
-47,100.00
-1,300.00
Total Expenses
564,500.00
564,500.00
524,600.00
567,700.00
486,700.00
Net Income from Continuing & Discontinued Operation
127,000.00
127,000.00
-31,700.00
-63,400.00
-31,400.00
Normalized Income
108,045.00
108,045.00
-33,315.00
-65,080.00
-29,580.00
Interest Income
2,000.00
2,000.00
800.00
200.00
1,200.00
Interest Expense
40,000.00
40,000.00
19,700.00
13,200.00
14,200.00
Net Interest Income
-38,200.00
-38,200.00
-22,800.00
-15,700.00
-15,800.00
EBIT
146,300.00
146,300.00
-11,100.00
-49,400.00
-15,800.00
EBITDA
182,200.00
182,200.00
24,700.00
-18,300.00
13,900.00
Reconciled Cost of Revenue
404,300.00
404,300.00
391,200.00
434,900.00
354,100.00
Reconciled Depreciation
35,900.00
35,900.00
35,800.00
31,100.00
29,700.00
Net Income from Continuing Operation Net Minority Interest
127,000.00
127,000.00
-31,700.00
-63,400.00
-31,400.00
Total Unusual Items Excluding Goodwill
22,300.00
22,300.00
1,900.00
2,400.00
-2,600.00
Total Unusual Items
22,300.00
22,300.00
1,900.00
2,400.00
-2,600.00
Normalized EBITDA
159,900.00
159,900.00
22,800.00
-20,700.00
16,500.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
3,345.00
3,345.00
285.00
720.00
-780.00
12/31/2020 - 11/19/1998

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

APTCF Advanced Proteome Therapeutics Corporation
0.0002
0.00%
 
CRPOF Ceapro Inc.
0.1845
0.00%
 
HPHA.DE Heidelberg Pharma AG
3.0500
-0.97%
 
UR9.F Clinuvel Pharmaceuticals Limited
9.05
+1.29%
 
PCIB.OL PCI Biotech Holding ASA
1.6860
-3.55%
 
ALDVI.PA Advicenne S.A.
1.7480
+2.22%
 
NSCI.L NetScientific plc
61.00
-3.17%
 
BBZA.F BB Biotech AG Ord
42.45
+1.07%
 
MDG1.DE Medigene AG
1.6400
-4.65%
 
MRZM Marizyme, Inc.
0.0950
0.00%